nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—muscle cancer	0.28	0.439	CbGbCtD
Perphenazine—CYP1A2—Dacarbazine—muscle cancer	0.0974	0.153	CbGbCtD
Perphenazine—CYP2C8—Etoposide—muscle cancer	0.0616	0.0965	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—muscle cancer	0.0554	0.0869	CbGbCtD
Perphenazine—CYP1A2—Etoposide—muscle cancer	0.0477	0.0747	CbGbCtD
Perphenazine—CYP3A4—Vincristine—muscle cancer	0.0272	0.0427	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—muscle cancer	0.0268	0.042	CbGbCtD
Perphenazine—CYP3A4—Etoposide—muscle cancer	0.025	0.0392	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—muscle cancer	0.017	0.0267	CbGbCtD
Perphenazine—HTR2A—hindlimb—muscle cancer	0.0042	0.0459	CbGeAlD
Perphenazine—Ileus paralytic—Vincristine—muscle cancer	0.0039	0.0371	CcSEcCtD
Perphenazine—HTR2A—appendage—muscle cancer	0.0036	0.0394	CbGeAlD
Perphenazine—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.0029	0.0276	CcSEcCtD
Perphenazine—Throat tightness—Etoposide—muscle cancer	0.00279	0.0265	CcSEcCtD
Perphenazine—Faecalith—Doxorubicin—muscle cancer	0.00248	0.0236	CcSEcCtD
Perphenazine—Faecaloma—Doxorubicin—muscle cancer	0.00248	0.0236	CcSEcCtD
Perphenazine—CYP2C18—vagina—muscle cancer	0.00241	0.0264	CbGeAlD
Perphenazine—Retinal disorder—Methotrexate—muscle cancer	0.00229	0.0218	CcSEcCtD
Perphenazine—AOX1—renal system—muscle cancer	0.00211	0.0231	CbGeAlD
Perphenazine—HTR6—head—muscle cancer	0.00209	0.0228	CbGeAlD
Perphenazine—CALM3—smooth muscle tissue—muscle cancer	0.00197	0.0216	CbGeAlD
Perphenazine—CALM2—embryo—muscle cancer	0.00197	0.0216	CbGeAlD
Perphenazine—CALM1—embryo—muscle cancer	0.00196	0.0215	CbGeAlD
Perphenazine—AOX1—cardiac atrium—muscle cancer	0.00189	0.0207	CbGeAlD
Perphenazine—CALM3—cardiac atrium—muscle cancer	0.0017	0.0186	CbGeAlD
Perphenazine—AOX1—tendon—muscle cancer	0.00165	0.018	CbGeAlD
Perphenazine—Sudden death—Methotrexate—muscle cancer	0.0016	0.0152	CcSEcCtD
Perphenazine—DRD1—head—muscle cancer	0.00155	0.017	CbGeAlD
Perphenazine—CALM2—smooth muscle tissue—muscle cancer	0.00155	0.017	CbGeAlD
Perphenazine—CALM1—smooth muscle tissue—muscle cancer	0.00154	0.0169	CbGeAlD
Perphenazine—AOX1—vagina—muscle cancer	0.00153	0.0167	CbGeAlD
Perphenazine—Urine output increased—Vincristine—muscle cancer	0.00153	0.0145	CcSEcCtD
Perphenazine—HTR1A—renal system—muscle cancer	0.00152	0.0166	CbGeAlD
Perphenazine—HTR7—smooth muscle tissue—muscle cancer	0.00151	0.0165	CbGeAlD
Perphenazine—CALM2—renal system—muscle cancer	0.00149	0.0163	CbGeAlD
Perphenazine—CALM1—renal system—muscle cancer	0.00149	0.0162	CbGeAlD
Perphenazine—CALM3—tendon—muscle cancer	0.00148	0.0162	CbGeAlD
Perphenazine—HTR7—renal system—muscle cancer	0.00145	0.0159	CbGeAlD
Perphenazine—CALM3—bone marrow—muscle cancer	0.00144	0.0157	CbGeAlD
Perphenazine—Lethargy—Dactinomycin—muscle cancer	0.0014	0.0133	CcSEcCtD
Perphenazine—Polyuria—Vincristine—muscle cancer	0.0014	0.0133	CcSEcCtD
Perphenazine—CALM3—vagina—muscle cancer	0.00138	0.0151	CbGeAlD
Perphenazine—AOX1—testis—muscle cancer	0.00136	0.0149	CbGeAlD
Perphenazine—CALM2—cardiac atrium—muscle cancer	0.00134	0.0146	CbGeAlD
Perphenazine—CALM1—cardiac atrium—muscle cancer	0.00133	0.0146	CbGeAlD
Perphenazine—CYP2C8—renal system—muscle cancer	0.00124	0.0135	CbGeAlD
Perphenazine—CALM3—testis—muscle cancer	0.00123	0.0134	CbGeAlD
Perphenazine—HTR2C—head—muscle cancer	0.00121	0.0132	CbGeAlD
Perphenazine—HTR2A—embryo—muscle cancer	0.0012	0.0131	CbGeAlD
Perphenazine—Dysphagia—Dactinomycin—muscle cancer	0.00119	0.0113	CcSEcCtD
Perphenazine—Cardiac arrest—Vincristine—muscle cancer	0.00116	0.0111	CcSEcCtD
Perphenazine—Urinary retention—Vincristine—muscle cancer	0.00116	0.0111	CcSEcCtD
Perphenazine—CALM2—tendon—muscle cancer	0.00116	0.0127	CbGeAlD
Perphenazine—CALM1—tendon—muscle cancer	0.00116	0.0127	CbGeAlD
Perphenazine—CYP1A2—renal system—muscle cancer	0.00116	0.0127	CbGeAlD
Perphenazine—Ataxia—Vincristine—muscle cancer	0.00115	0.011	CcSEcCtD
Perphenazine—HTR7—tendon—muscle cancer	0.00113	0.0124	CbGeAlD
Perphenazine—CALM2—bone marrow—muscle cancer	0.00113	0.0123	CbGeAlD
Perphenazine—Pancytopenia—Dactinomycin—muscle cancer	0.00113	0.0107	CcSEcCtD
Perphenazine—HRH1—smooth muscle tissue—muscle cancer	0.00113	0.0123	CbGeAlD
Perphenazine—CALM1—bone marrow—muscle cancer	0.00112	0.0123	CbGeAlD
Perphenazine—CYP2B6—renal system—muscle cancer	0.00111	0.0121	CbGeAlD
Perphenazine—CALM2—vagina—muscle cancer	0.00108	0.0118	CbGeAlD
Perphenazine—Muscular weakness—Vincristine—muscle cancer	0.00108	0.0103	CcSEcCtD
Perphenazine—CALM1—vagina—muscle cancer	0.00108	0.0118	CbGeAlD
Perphenazine—CYP2C19—vagina—muscle cancer	0.00103	0.0112	CbGeAlD
Perphenazine—Anaphylactoid reaction—Etoposide—muscle cancer	0.00103	0.00975	CcSEcCtD
Perphenazine—HTR1A—head—muscle cancer	0.00102	0.0111	CbGeAlD
Perphenazine—Pancytopenia—Vincristine—muscle cancer	0.00101	0.00956	CcSEcCtD
Perphenazine—CALM2—head—muscle cancer	0.000998	0.0109	CbGeAlD
Perphenazine—CALM1—head—muscle cancer	0.000994	0.0109	CbGeAlD
Perphenazine—Agranulocytosis—Dactinomycin—muscle cancer	0.000986	0.00938	CcSEcCtD
Perphenazine—HTR7—head—muscle cancer	0.000971	0.0106	CbGeAlD
Perphenazine—Photosensitivity reaction—Vincristine—muscle cancer	0.000966	0.00919	CcSEcCtD
Perphenazine—CALM2—testis—muscle cancer	0.000964	0.0106	CbGeAlD
Perphenazine—CALM1—testis—muscle cancer	0.00096	0.0105	CbGeAlD
Perphenazine—ADRA2A—cardiac atrium—muscle cancer	0.000953	0.0104	CbGeAlD
Perphenazine—Cardiac arrest—Etoposide—muscle cancer	0.000944	0.00897	CcSEcCtD
Perphenazine—HTR2A—smooth muscle tissue—muscle cancer	0.00094	0.0103	CbGeAlD
Perphenazine—HTR7—testis—muscle cancer	0.000938	0.0103	CbGeAlD
Perphenazine—DRD2—head—muscle cancer	0.000918	0.01	CbGeAlD
Perphenazine—HTR2A—renal system—muscle cancer	0.000905	0.0099	CbGeAlD
Perphenazine—CYP2C8—vagina—muscle cancer	0.000896	0.0098	CbGeAlD
Perphenazine—DRD2—testis—muscle cancer	0.000887	0.0097	CbGeAlD
Perphenazine—Glycosuria—Doxorubicin—muscle cancer	0.000875	0.00832	CcSEcCtD
Perphenazine—Dysarthria—Methotrexate—muscle cancer	0.000866	0.00823	CcSEcCtD
Perphenazine—Dysphagia—Etoposide—muscle cancer	0.000858	0.00816	CcSEcCtD
Perphenazine—Blood disorder—Doxorubicin—muscle cancer	0.000849	0.00807	CcSEcCtD
Perphenazine—HRH1—tendon—muscle cancer	0.000846	0.00925	CbGeAlD
Perphenazine—Hypoaesthesia—Vincristine—muscle cancer	0.000843	0.00802	CcSEcCtD
Perphenazine—Liver injury—Doxorubicin—muscle cancer	0.000843	0.00801	CcSEcCtD
Perphenazine—CYP3A4—renal system—muscle cancer	0.000838	0.00916	CbGeAlD
Perphenazine—ADRA2A—tendon—muscle cancer	0.000831	0.00909	CbGeAlD
Perphenazine—Erythema—Dactinomycin—muscle cancer	0.000826	0.00785	CcSEcCtD
Perphenazine—CYP2D6—renal system—muscle cancer	0.000824	0.00902	CbGeAlD
Perphenazine—Pancytopenia—Etoposide—muscle cancer	0.000815	0.00775	CcSEcCtD
Perphenazine—Jaundice cholestatic—Doxorubicin—muscle cancer	0.000807	0.00767	CcSEcCtD
Perphenazine—Amenorrhoea—Doxorubicin—muscle cancer	0.000807	0.00767	CcSEcCtD
Perphenazine—CYP2B6—vagina—muscle cancer	0.000803	0.00879	CbGeAlD
Perphenazine—CYP2C8—testis—muscle cancer	0.000799	0.00874	CbGeAlD
Perphenazine—HRH1—vagina—muscle cancer	0.000785	0.00858	CbGeAlD
Perphenazine—ADRA2A—vagina—muscle cancer	0.000771	0.00843	CbGeAlD
Perphenazine—Dyskinesia—Doxorubicin—muscle cancer	0.000754	0.00717	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—muscle cancer	0.00075	0.00713	CcSEcCtD
Perphenazine—Jaundice—Etoposide—muscle cancer	0.000745	0.00709	CcSEcCtD
Perphenazine—CYP2B6—head—muscle cancer	0.000742	0.00812	CbGeAlD
Perphenazine—Urine output increased—Methotrexate—muscle cancer	0.00074	0.00704	CcSEcCtD
Perphenazine—Leukopenia—Dactinomycin—muscle cancer	0.000739	0.00703	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—muscle cancer	0.000733	0.00697	CcSEcCtD
Perphenazine—HRH1—head—muscle cancer	0.000725	0.00793	CbGeAlD
Perphenazine—CYP2B6—testis—muscle cancer	0.000717	0.00784	CbGeAlD
Perphenazine—Agranulocytosis—Etoposide—muscle cancer	0.000714	0.00679	CcSEcCtD
Perphenazine—ADRA2A—head—muscle cancer	0.000712	0.00779	CbGeAlD
Perphenazine—Hepatocellular injury—Doxorubicin—muscle cancer	0.000709	0.00674	CcSEcCtD
Perphenazine—HTR2A—tendon—muscle cancer	0.000706	0.00773	CbGeAlD
Perphenazine—Abnormal dreams—Doxorubicin—muscle cancer	0.000701	0.00666	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—muscle cancer	0.000701	0.00666	CcSEcCtD
Perphenazine—HRH1—testis—muscle cancer	0.0007	0.00766	CbGeAlD
Perphenazine—Salivary hypersecretion—Doxorubicin—muscle cancer	0.000689	0.00655	CcSEcCtD
Perphenazine—ADRA2A—testis—muscle cancer	0.000688	0.00752	CbGeAlD
Perphenazine—Hypoaesthesia—Etoposide—muscle cancer	0.000683	0.0065	CcSEcCtD
Perphenazine—Agitation—Vincristine—muscle cancer	0.000678	0.00645	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—muscle cancer	0.000677	0.00644	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—muscle cancer	0.000677	0.00644	CcSEcCtD
Perphenazine—Infection—Dactinomycin—muscle cancer	0.000669	0.00637	CcSEcCtD
Perphenazine—Leukopenia—Vincristine—muscle cancer	0.00066	0.00628	CcSEcCtD
Perphenazine—HTR2A—vagina—muscle cancer	0.000655	0.00717	CbGeAlD
Perphenazine—Anorexia—Dactinomycin—muscle cancer	0.000642	0.00611	CcSEcCtD
Perphenazine—Convulsion—Vincristine—muscle cancer	0.000639	0.00608	CcSEcCtD
Perphenazine—Hypertension—Vincristine—muscle cancer	0.000637	0.00606	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00063	0.00599	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000614	0.00584	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—muscle cancer	0.000607	0.00577	CcSEcCtD
Perphenazine—HTR2A—head—muscle cancer	0.000605	0.00662	CbGeAlD
Perphenazine—Anaphylactic shock—Vincristine—muscle cancer	0.000602	0.00573	CcSEcCtD
Perphenazine—Infection—Vincristine—muscle cancer	0.000598	0.00569	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—muscle cancer	0.000586	0.00557	CcSEcCtD
Perphenazine—Decreased appetite—Dactinomycin—muscle cancer	0.000586	0.00557	CcSEcCtD
Perphenazine—HTR2A—testis—muscle cancer	0.000585	0.0064	CbGeAlD
Perphenazine—Pain—Dactinomycin—muscle cancer	0.000576	0.00548	CcSEcCtD
Perphenazine—Muscle spasms—Etoposide—muscle cancer	0.000575	0.00546	CcSEcCtD
Perphenazine—Anorexia—Vincristine—muscle cancer	0.000574	0.00546	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—muscle cancer	0.000573	0.00545	CcSEcCtD
Perphenazine—Hypotension—Vincristine—muscle cancer	0.000563	0.00535	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—muscle cancer	0.000559	0.00531	CcSEcCtD
Perphenazine—CYP2D6—head—muscle cancer	0.000551	0.00603	CbGeAlD
Perphenazine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000545	0.00519	CcSEcCtD
Perphenazine—Insomnia—Vincristine—muscle cancer	0.000545	0.00518	CcSEcCtD
Perphenazine—Leukopenia—Etoposide—muscle cancer	0.000535	0.00509	CcSEcCtD
Perphenazine—CYP2D6—testis—muscle cancer	0.000533	0.00583	CbGeAlD
Perphenazine—Body temperature increased—Dactinomycin—muscle cancer	0.000533	0.00507	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000532	0.00506	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000527	0.00502	CcSEcCtD
Perphenazine—Loss of consciousness—Etoposide—muscle cancer	0.000525	0.00499	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—muscle cancer	0.000525	0.00499	CcSEcCtD
Perphenazine—Decreased appetite—Vincristine—muscle cancer	0.000523	0.00498	CcSEcCtD
Perphenazine—Cough—Etoposide—muscle cancer	0.000521	0.00496	CcSEcCtD
Perphenazine—Convulsion—Etoposide—muscle cancer	0.000518	0.00492	CcSEcCtD
Perphenazine—Hypertension—Etoposide—muscle cancer	0.000516	0.00491	CcSEcCtD
Perphenazine—Constipation—Vincristine—muscle cancer	0.000515	0.0049	CcSEcCtD
Perphenazine—Pain—Vincristine—muscle cancer	0.000515	0.0049	CcSEcCtD
Perphenazine—Asthma—Methotrexate—muscle cancer	0.000514	0.00489	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—muscle cancer	0.000509	0.00484	CcSEcCtD
Perphenazine—Hypersensitivity—Dactinomycin—muscle cancer	0.000497	0.00472	CcSEcCtD
Perphenazine—Confusional state—Etoposide—muscle cancer	0.000492	0.00468	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—muscle cancer	0.000489	0.00465	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—muscle cancer	0.000488	0.00464	CcSEcCtD
Perphenazine—Anaphylactic shock—Etoposide—muscle cancer	0.000488	0.00464	CcSEcCtD
Perphenazine—Infection—Etoposide—muscle cancer	0.000485	0.00461	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—muscle cancer	0.000484	0.0046	CcSEcCtD
Perphenazine—Tachycardia—Etoposide—muscle cancer	0.000476	0.00453	CcSEcCtD
Perphenazine—Body temperature increased—Vincristine—muscle cancer	0.000476	0.00453	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00047	0.00447	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000469	0.00446	CcSEcCtD
Perphenazine—Anorexia—Etoposide—muscle cancer	0.000465	0.00442	CcSEcCtD
Perphenazine—Diarrhoea—Dactinomycin—muscle cancer	0.000461	0.00438	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—muscle cancer	0.000458	0.00436	CcSEcCtD
Perphenazine—Hypotension—Etoposide—muscle cancer	0.000456	0.00433	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—muscle cancer	0.000454	0.00432	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—muscle cancer	0.000445	0.00423	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—muscle cancer	0.000445	0.00423	CcSEcCtD
Perphenazine—Hypersensitivity—Vincristine—muscle cancer	0.000444	0.00422	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—muscle cancer	0.00044	0.00419	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—muscle cancer	0.000435	0.00414	CcSEcCtD
Perphenazine—Somnolence—Etoposide—muscle cancer	0.000434	0.00412	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—muscle cancer	0.000427	0.00406	CcSEcCtD
Perphenazine—Decreased appetite—Etoposide—muscle cancer	0.000424	0.00403	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—muscle cancer	0.000422	0.00402	CcSEcCtD
Perphenazine—Constipation—Etoposide—muscle cancer	0.000417	0.00397	CcSEcCtD
Perphenazine—Pain—Etoposide—muscle cancer	0.000417	0.00397	CcSEcCtD
Perphenazine—Diarrhoea—Vincristine—muscle cancer	0.000412	0.00392	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000406	0.00386	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000401	0.00382	CcSEcCtD
Perphenazine—Dizziness—Vincristine—muscle cancer	0.000398	0.00379	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—muscle cancer	0.000397	0.00377	CcSEcCtD
Perphenazine—Urticaria—Etoposide—muscle cancer	0.000387	0.00368	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—muscle cancer	0.000387	0.00368	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—muscle cancer	0.000386	0.00367	CcSEcCtD
Perphenazine—Headache—Vincristine—muscle cancer	0.000377	0.00359	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—muscle cancer	0.00037	0.00352	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—muscle cancer	0.000362	0.00345	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—muscle cancer	0.000359	0.00342	CcSEcCtD
Perphenazine—Erythema—Methotrexate—muscle cancer	0.000358	0.0034	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000354	0.00337	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—muscle cancer	0.000351	0.00334	CcSEcCtD
Perphenazine—Pruritus—Etoposide—muscle cancer	0.000345	0.00328	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—muscle cancer	0.000337	0.00321	CcSEcCtD
Perphenazine—Diarrhoea—Etoposide—muscle cancer	0.000334	0.00317	CcSEcCtD
Perphenazine—Dizziness—Etoposide—muscle cancer	0.000323	0.00307	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—muscle cancer	0.00032	0.00305	CcSEcCtD
Perphenazine—Cough—Methotrexate—muscle cancer	0.000312	0.00297	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—muscle cancer	0.00031	0.00295	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—muscle cancer	0.00031	0.00295	CcSEcCtD
Perphenazine—Headache—Etoposide—muscle cancer	0.000306	0.00291	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—muscle cancer	0.000298	0.00283	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—muscle cancer	0.000295	0.0028	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—muscle cancer	0.000292	0.00278	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—muscle cancer	0.000292	0.00278	CcSEcCtD
Perphenazine—Infection—Methotrexate—muscle cancer	0.00029	0.00276	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—muscle cancer	0.000285	0.00271	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—muscle cancer	0.000278	0.00265	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—muscle cancer	0.000278	0.00264	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—muscle cancer	0.000277	0.00264	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—muscle cancer	0.000273	0.0026	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—muscle cancer	0.000272	0.00259	CcSEcCtD
Perphenazine—Cough—Doxorubicin—muscle cancer	0.00027	0.00257	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—muscle cancer	0.000269	0.00255	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—muscle cancer	0.000268	0.00254	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—muscle cancer	0.000264	0.00251	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—muscle cancer	0.00026	0.00248	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—muscle cancer	0.00026	0.00247	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—muscle cancer	0.000258	0.00245	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—muscle cancer	0.000255	0.00243	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—muscle cancer	0.000254	0.00242	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000253	0.00241	CcSEcCtD
Perphenazine—Infection—Doxorubicin—muscle cancer	0.000251	0.00239	CcSEcCtD
Perphenazine—Pain—Methotrexate—muscle cancer	0.00025	0.00238	CcSEcCtD
Perphenazine—Shock—Doxorubicin—muscle cancer	0.000249	0.00237	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—muscle cancer	0.000247	0.00235	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—muscle cancer	0.000241	0.00229	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—muscle cancer	0.000236	0.00225	CcSEcCtD
Perphenazine—Urticaria—Methotrexate—muscle cancer	0.000232	0.00221	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—muscle cancer	0.000231	0.0022	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—muscle cancer	0.000229	0.00218	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—muscle cancer	0.000226	0.00214	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—muscle cancer	0.000225	0.00214	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—muscle cancer	0.00022	0.00209	CcSEcCtD
Perphenazine—Pain—Doxorubicin—muscle cancer	0.000216	0.00206	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—muscle cancer	0.000216	0.00206	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—muscle cancer	0.000215	0.00205	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—muscle cancer	0.000207	0.00197	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—muscle cancer	0.000201	0.00191	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—muscle cancer	0.0002	0.0019	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—muscle cancer	0.0002	0.0019	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—muscle cancer	0.000193	0.00184	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—muscle cancer	0.000186	0.00177	CcSEcCtD
Perphenazine—Headache—Methotrexate—muscle cancer	0.000183	0.00174	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—muscle cancer	0.000179	0.0017	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—muscle cancer	0.000173	0.00165	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—muscle cancer	0.000167	0.00159	CcSEcCtD
Perphenazine—Headache—Doxorubicin—muscle cancer	0.000158	0.00151	CcSEcCtD
Perphenazine—HTR2A—Signaling by GPCR—PTCH1—muscle cancer	9.93e-05	0.000599	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—IGF2—muscle cancer	9.91e-05	0.000598	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—PTCH1—muscle cancer	9.91e-05	0.000598	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—CNR1—muscle cancer	9.7e-05	0.000586	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—CNR1—muscle cancer	9.65e-05	0.000583	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—IGF2—muscle cancer	9.59e-05	0.000579	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—IGF2—muscle cancer	9.59e-05	0.000579	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD34—muscle cancer	9.53e-05	0.000575	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—CNR1—muscle cancer	9.38e-05	0.000566	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—FH—muscle cancer	9.26e-05	0.000559	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—CNR1—muscle cancer	9.23e-05	0.000557	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD34—muscle cancer	9.22e-05	0.000556	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD34—muscle cancer	9.22e-05	0.000556	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—CNR1—muscle cancer	9.21e-05	0.000556	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—PTCH1—muscle cancer	9.17e-05	0.000554	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—PTCH1—muscle cancer	9.16e-05	0.000553	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.15e-05	0.000553	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—PTCH1—muscle cancer	9.03e-05	0.000545	CbGpPWpGaD
Perphenazine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	8.84e-05	0.000534	CbGpPWpGaD
Perphenazine—CALM3—Neuronal System—MDM2—muscle cancer	8.81e-05	0.000532	CbGpPWpGaD
Perphenazine—CALM3—Signaling by NGF—MDM2—muscle cancer	8.64e-05	0.000522	CbGpPWpGaD
Perphenazine—CALM2—Neuronal System—MDM2—muscle cancer	8.52e-05	0.000515	CbGpPWpGaD
Perphenazine—CALM1—Neuronal System—MDM2—muscle cancer	8.52e-05	0.000515	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—CNR1—muscle cancer	8.52e-05	0.000514	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—FH—muscle cancer	8.51e-05	0.000514	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—FH—muscle cancer	8.44e-05	0.00051	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—CNR1—muscle cancer	8.4e-05	0.000507	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—CNR1—muscle cancer	8.38e-05	0.000506	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CNR1—muscle cancer	8.36e-05	0.000505	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—MDM2—muscle cancer	8.36e-05	0.000505	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—MDM2—muscle cancer	8.36e-05	0.000505	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PTCH1—muscle cancer	8.24e-05	0.000498	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—FOXO1—muscle cancer	8.21e-05	0.000496	CbGpPWpGaD
Perphenazine—AOX1—Disease—MDM2—muscle cancer	8.2e-05	0.000495	CbGpPWpGaD
Perphenazine—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	8.06e-05	0.000487	CbGpPWpGaD
Perphenazine—DRD2—Circadian rythm related genes—TP53—muscle cancer	8.05e-05	0.000486	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PTCH1—muscle cancer	7.97e-05	0.000481	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PTCH1—muscle cancer	7.97e-05	0.000481	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—FOXO1—muscle cancer	7.94e-05	0.00048	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—FOXO1—muscle cancer	7.94e-05	0.00048	CbGpPWpGaD
Perphenazine—AOX1—Disease—PTGS2—muscle cancer	7.9e-05	0.000477	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PTCH1—muscle cancer	7.9e-05	0.000477	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—FOXO4—muscle cancer	7.89e-05	0.000476	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—FOXO1—muscle cancer	7.88e-05	0.000476	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—FOXO4—muscle cancer	7.88e-05	0.000476	CbGpPWpGaD
Perphenazine—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.8e-05	0.000471	CbGpPWpGaD
Perphenazine—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.8e-05	0.000471	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CNR1—muscle cancer	7.74e-05	0.000467	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CNR1—muscle cancer	7.73e-05	0.000467	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—FOXO1—muscle cancer	7.63e-05	0.000461	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—FOXO1—muscle cancer	7.63e-05	0.000461	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CNR1—muscle cancer	7.62e-05	0.00046	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—MED12—muscle cancer	7.38e-05	0.000446	CbGpPWpGaD
Perphenazine—CALM3—Disease—ENO2—muscle cancer	7.33e-05	0.000443	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—FH—muscle cancer	7.21e-05	0.000436	CbGpPWpGaD
Perphenazine—CALM2—Disease—ENO2—muscle cancer	7.09e-05	0.000428	CbGpPWpGaD
Perphenazine—CALM1—Disease—ENO2—muscle cancer	7.09e-05	0.000428	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CNR1—muscle cancer	6.96e-05	0.00042	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—MED12—muscle cancer	6.92e-05	0.000418	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—FOXO4—muscle cancer	6.79e-05	0.00041	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PTCH1—muscle cancer	6.79e-05	0.00041	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PTCH1—muscle cancer	6.75e-05	0.000408	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—MED12—muscle cancer	6.74e-05	0.000407	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—ENO2—muscle cancer	6.73e-05	0.000406	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CNR1—muscle cancer	6.73e-05	0.000406	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CNR1—muscle cancer	6.73e-05	0.000406	CbGpPWpGaD
Perphenazine—CALM3—Disease—HMGA1—muscle cancer	6.67e-05	0.000402	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CNR1—muscle cancer	6.66e-05	0.000402	CbGpPWpGaD
Perphenazine—AOX1—Metabolism—PTGS2—muscle cancer	6.62e-05	0.0004	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—MED12—muscle cancer	6.52e-05	0.000393	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—MED12—muscle cancer	6.52e-05	0.000393	CbGpPWpGaD
Perphenazine—CALM3—Immune System—FOXO4—muscle cancer	6.48e-05	0.000391	CbGpPWpGaD
Perphenazine—CALM1—Disease—HMGA1—muscle cancer	6.45e-05	0.000389	CbGpPWpGaD
Perphenazine—CALM2—Disease—HMGA1—muscle cancer	6.45e-05	0.000389	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IGF2—muscle cancer	6.33e-05	0.000382	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IGF2—muscle cancer	6.32e-05	0.000382	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—ENO2—muscle cancer	6.31e-05	0.000381	CbGpPWpGaD
Perphenazine—CALM1—Immune System—FOXO4—muscle cancer	6.26e-05	0.000378	CbGpPWpGaD
Perphenazine—CALM2—Immune System—FOXO4—muscle cancer	6.26e-05	0.000378	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—KIT—muscle cancer	6.26e-05	0.000378	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—ENO2—muscle cancer	6.14e-05	0.000371	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—KIT—muscle cancer	6.05e-05	0.000365	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—KIT—muscle cancer	6.05e-05	0.000365	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—KIT—muscle cancer	6.01e-05	0.000363	CbGpPWpGaD
Perphenazine—CALM3—Disease—FOXO4—muscle cancer	5.98e-05	0.000361	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PTCH1—muscle cancer	5.96e-05	0.00036	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—ENO2—muscle cancer	5.94e-05	0.000359	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—ENO2—muscle cancer	5.94e-05	0.000359	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PTCH1—muscle cancer	5.87e-05	0.000354	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—MED12—muscle cancer	5.86e-05	0.000354	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PTCH1—muscle cancer	5.85e-05	0.000353	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—FOXO4—muscle cancer	5.84e-05	0.000352	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—FOXO1—muscle cancer	5.82e-05	0.000352	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—FOXO1—muscle cancer	5.82e-05	0.000351	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—KIT—muscle cancer	5.81e-05	0.000351	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—KIT—muscle cancer	5.81e-05	0.000351	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—FOXO4—muscle cancer	5.81e-05	0.000351	CbGpPWpGaD
Perphenazine—CALM1—Disease—FOXO4—muscle cancer	5.78e-05	0.000349	CbGpPWpGaD
Perphenazine—CALM2—Disease—FOXO4—muscle cancer	5.78e-05	0.000349	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CNR1—muscle cancer	5.73e-05	0.000346	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CNR1—muscle cancer	5.7e-05	0.000344	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—FH—muscle cancer	5.57e-05	0.000336	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IGF2—muscle cancer	5.45e-05	0.000329	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ENO2—muscle cancer	5.34e-05	0.000323	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTCH1—muscle cancer	5.34e-05	0.000322	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—MED12—muscle cancer	5.23e-05	0.000316	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—FOXO4—muscle cancer	5.13e-05	0.000309	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—FOXO4—muscle cancer	5.04e-05	0.000305	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—FOXO4—muscle cancer	5.03e-05	0.000304	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CNR1—muscle cancer	5.03e-05	0.000304	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—FOXO1—muscle cancer	5.01e-05	0.000303	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CNR1—muscle cancer	4.95e-05	0.000299	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CNR1—muscle cancer	4.94e-05	0.000298	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—MDM2—muscle cancer	4.93e-05	0.000297	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTCH1—muscle cancer	4.87e-05	0.000294	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—MED12—muscle cancer	4.81e-05	0.00029	CbGpPWpGaD
Perphenazine—CALM3—Immune System—FOXO1—muscle cancer	4.78e-05	0.000289	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—MED12—muscle cancer	4.77e-05	0.000288	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ENO2—muscle cancer	4.77e-05	0.000288	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—MDM2—muscle cancer	4.77e-05	0.000288	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—MDM2—muscle cancer	4.77e-05	0.000288	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—MDM2—muscle cancer	4.73e-05	0.000286	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTCH1—muscle cancer	4.71e-05	0.000284	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTCH1—muscle cancer	4.71e-05	0.000284	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IGF2—muscle cancer	4.69e-05	0.000283	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IGF2—muscle cancer	4.66e-05	0.000281	CbGpPWpGaD
Perphenazine—CALM2—Immune System—FOXO1—muscle cancer	4.63e-05	0.000279	CbGpPWpGaD
Perphenazine—CALM1—Immune System—FOXO1—muscle cancer	4.63e-05	0.000279	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—FOXO4—muscle cancer	4.59e-05	0.000277	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—MDM2—muscle cancer	4.58e-05	0.000276	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—MDM2—muscle cancer	4.58e-05	0.000276	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—VEGFA—muscle cancer	4.56e-05	0.000275	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CNR1—muscle cancer	4.5e-05	0.000272	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—PTGS2—muscle cancer	4.47e-05	0.00027	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—KIT—muscle cancer	4.44e-05	0.000268	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KIT—muscle cancer	4.43e-05	0.000268	CbGpPWpGaD
Perphenazine—CALM3—Disease—FOXO1—muscle cancer	4.42e-05	0.000267	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ENO2—muscle cancer	4.39e-05	0.000265	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ENO2—muscle cancer	4.35e-05	0.000263	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—FOXO1—muscle cancer	4.31e-05	0.00026	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—FOXO1—muscle cancer	4.29e-05	0.000259	CbGpPWpGaD
Perphenazine—CALM2—Disease—FOXO1—muscle cancer	4.27e-05	0.000258	CbGpPWpGaD
Perphenazine—CALM1—Disease—FOXO1—muscle cancer	4.27e-05	0.000258	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—FOXO4—muscle cancer	4.19e-05	0.000253	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.18e-05	0.000252	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—VEGFA—muscle cancer	4.16e-05	0.000251	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IGF2—muscle cancer	4.11e-05	0.000248	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CNR1—muscle cancer	4.11e-05	0.000248	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—MED12—muscle cancer	4.08e-05	0.000246	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—FOXO4—muscle cancer	4.05e-05	0.000245	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—FOXO4—muscle cancer	4.05e-05	0.000245	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IGF2—muscle cancer	4.05e-05	0.000244	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IGF2—muscle cancer	4.04e-05	0.000244	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—VEGFA—muscle cancer	4.02e-05	0.000243	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—VEGFA—muscle cancer	4.02e-05	0.000243	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CNR1—muscle cancer	3.98e-05	0.00024	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CNR1—muscle cancer	3.98e-05	0.00024	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KIT—muscle cancer	3.82e-05	0.000231	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—FOXO1—muscle cancer	3.79e-05	0.000229	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.73e-05	0.000225	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—FOXO1—muscle cancer	3.72e-05	0.000225	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—FOXO1—muscle cancer	3.72e-05	0.000224	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ENO2—muscle cancer	3.72e-05	0.000224	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IGF2—muscle cancer	3.68e-05	0.000222	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KIT—muscle cancer	3.64e-05	0.00022	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KIT—muscle cancer	3.53e-05	0.000213	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KIT—muscle cancer	3.53e-05	0.000213	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MDM2—muscle cancer	3.5e-05	0.000211	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MDM2—muscle cancer	3.49e-05	0.000211	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—TP53—muscle cancer	3.44e-05	0.000208	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.4e-05	0.000205	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—FOXO1—muscle cancer	3.39e-05	0.000205	CbGpPWpGaD
Perphenazine—CALM3—Disease—KIT—muscle cancer	3.36e-05	0.000203	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IGF2—muscle cancer	3.36e-05	0.000203	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KIT—muscle cancer	3.29e-05	0.000198	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KIT—muscle cancer	3.27e-05	0.000197	CbGpPWpGaD
Perphenazine—CALM1—Disease—KIT—muscle cancer	3.25e-05	0.000196	CbGpPWpGaD
Perphenazine—CALM2—Disease—KIT—muscle cancer	3.25e-05	0.000196	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IGF2—muscle cancer	3.25e-05	0.000196	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IGF2—muscle cancer	3.25e-05	0.000196	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MED12—muscle cancer	3.15e-05	0.00019	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—TP53—muscle cancer	3.14e-05	0.00019	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—FOXO1—muscle cancer	3.09e-05	0.000187	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—TP53—muscle cancer	3.04e-05	0.000183	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—TP53—muscle cancer	3.04e-05	0.000183	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MDM2—muscle cancer	3.01e-05	0.000182	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—FOXO1—muscle cancer	2.99e-05	0.000181	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—FOXO1—muscle cancer	2.99e-05	0.000181	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.91e-05	0.000175	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KIT—muscle cancer	2.88e-05	0.000174	CbGpPWpGaD
Perphenazine—CALM3—Immune System—MDM2—muscle cancer	2.87e-05	0.000173	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ENO2—muscle cancer	2.87e-05	0.000173	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KIT—muscle cancer	2.84e-05	0.000171	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KIT—muscle cancer	2.83e-05	0.000171	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MDM2—muscle cancer	2.78e-05	0.000168	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MDM2—muscle cancer	2.78e-05	0.000168	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—VEGFA—muscle cancer	2.65e-05	0.00016	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—VEGFA—muscle cancer	2.65e-05	0.00016	CbGpPWpGaD
Perphenazine—CALM3—Disease—MDM2—muscle cancer	2.65e-05	0.00016	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MDM2—muscle cancer	2.59e-05	0.000156	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KIT—muscle cancer	2.58e-05	0.000156	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MDM2—muscle cancer	2.57e-05	0.000155	CbGpPWpGaD
Perphenazine—CALM1—Disease—MDM2—muscle cancer	2.56e-05	0.000155	CbGpPWpGaD
Perphenazine—CALM2—Disease—MDM2—muscle cancer	2.56e-05	0.000155	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTGS2—muscle cancer	2.55e-05	0.000154	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTGS2—muscle cancer	2.47e-05	0.000149	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTGS2—muscle cancer	2.47e-05	0.000149	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KIT—muscle cancer	2.36e-05	0.000142	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTGS2—muscle cancer	2.34e-05	0.000142	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—VEGFA—muscle cancer	2.28e-05	0.000138	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KIT—muscle cancer	2.28e-05	0.000138	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KIT—muscle cancer	2.28e-05	0.000138	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MDM2—muscle cancer	2.27e-05	0.000137	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MDM2—muscle cancer	2.24e-05	0.000135	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MDM2—muscle cancer	2.23e-05	0.000135	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—muscle cancer	2.2e-05	0.000133	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—muscle cancer	2.14e-05	0.000129	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—muscle cancer	2.07e-05	0.000125	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—muscle cancer	2.07e-05	0.000125	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MDM2—muscle cancer	2.03e-05	0.000123	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—muscle cancer	2.01e-05	0.000121	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—muscle cancer	2e-05	0.000121	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—muscle cancer	1.96e-05	0.000119	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—muscle cancer	1.95e-05	0.000118	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—muscle cancer	1.86e-05	0.000112	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MDM2—muscle cancer	1.86e-05	0.000112	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MDM2—muscle cancer	1.79e-05	0.000108	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MDM2—muscle cancer	1.79e-05	0.000108	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—muscle cancer	1.73e-05	0.000104	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—muscle cancer	1.73e-05	0.000104	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—muscle cancer	1.7e-05	0.000102	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—muscle cancer	1.69e-05	0.000102	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—muscle cancer	1.66e-05	0.0001	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—muscle cancer	1.54e-05	9.32e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—muscle cancer	1.53e-05	9.22e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—muscle cancer	1.51e-05	9.14e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—muscle cancer	1.48e-05	8.96e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—muscle cancer	1.48e-05	8.92e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—muscle cancer	1.41e-05	8.51e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—muscle cancer	1.36e-05	8.23e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—muscle cancer	1.36e-05	8.23e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—muscle cancer	1.3e-05	7.87e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—muscle cancer	1.29e-05	7.81e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—muscle cancer	1.28e-05	7.74e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—muscle cancer	1.28e-05	7.73e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—muscle cancer	1.17e-05	7.04e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—muscle cancer	1.06e-05	6.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—muscle cancer	1.03e-05	6.22e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—muscle cancer	1.03e-05	6.22e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—muscle cancer	9.99e-06	6.03e-05	CbGpPWpGaD
